WDAY Beat on Everything. The Guide Is the Problem.
Workday’s Q2 was nearly clean. A light subscription outlook pushed shares down after hours. That dislocation is worth examining carefully.
Who Confirmed Nvidia’s 9% Day and Who Didn’t
The breadth scorecard from Thursday's historic move shows where the chip trade is concentrated and where it isn't.
Eaton Is the AI Trade Nobody Calls AI
Record Q2 sales, a Trane partnership, and a 307 GW data center backlog that compounds quietly.
Your T-Bill Ladder Has a New Ally
Bessent’s Treasury twist and the GENIUS Act are reshaping the short end. Here is what cash holders should know.
34 Days to a Margin Event Options Haven’t Priced
September 29 brings 100% Section 232 duties on patented drugs and APIs for importers without an onshoring plan or MFN…
Chargeback Rates Are Now the Key Metric in HIMS
Visa monitoring makes Hims’ GLP-1 subscriptions legible from the outside.
What Nasdaq Multiples Don’t Price In
Taiwan’s record $35 billion defense budget puts a price on tail risk. The question is whether chip stocks reflect any…
Shell’s Crackers Are for Sale. Exxon or LYB Should Buy Them.
At up to $8 billion for U.S. ethane-advantaged capacity, this is a trough acquisition question. The rational owner matters as…
Oracle Just Partnered With Its Biggest Rival
AWS signed. The stock is down 59%. The backlog is $638B. One of these is wrong.
The Unloved Sector Just Beat Chips
Healthcare has outrun SOXX since June. The flows have barely started.